Company news
CDT Equity Inc. news in 2024
CDT Equity Inc.'s news releases, calls and decks from 2024, newest first.
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
December 11, 2024
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
November 20, 2024
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
November 18, 2024
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
November 3, 2024
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
October 31, 2024
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
August 11, 2024
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
July 15, 2024
Conduit Pharmaceuticals to Join Russell 3000® Index
June 12, 2024
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
March 18, 2024
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
March 10, 2024